More than just availability: Who has access and who administers take-home naloxone in Baltimore, MD
Lauren Dayton(Johns Hopkins University), Carl A. Latkin(Johns Hopkins University), Karin E. Tobin, Melissa Davey‐Rothwell(Johns Hopkins University), Rachel E. Gicquelais(Johns Hopkins University), Abenaa Jones(Johns Hopkins University), Michael Fingerhood, Xiangrong Kong(Johns Hopkins University), Oluwaseun Falade‐Nwulia(Johns Hopkins University)
Cited by 54
Related Papers
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection
|Annals of Internal Medicine|2017|694
The neglected health of international migrant workers in the COVID-19 epidemic
|The Lancet Psychiatry|2020|402
Adverse interactions between antifungal azoles and vincristine: review and analysis of cases
|Mycoses|2011|159
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review
|UNC Libraries|2020|111